Semnur Pharmaceuticals, Inc. (SMNRW) Operating income 2023–2025
Semnur Pharmaceuticals, Inc. (SMNRW) annual operating income history from SEC filings — each fiscal year as reported.
-$160.4MFY2025 · since FY2023: -$3.2M → -$160.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$160.4M | -3320.4% |
| FY2024 | -$4.7M | -47.8% |
| FY2023 | -$3.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SMNRW financial trends
SMNRW RevenueSMNRW Net incomeSMNRW Net marginSMNRW Gross profitSMNRW Gross marginSMNRW Operating marginSMNRW Operating cash flowSMNRW Free cash flowSMNRW Capital expendituresSMNRW Return on equitySMNRW Stock buybacksSMNRW Dividends paidSMNRW Total assetsSMNRW Total liabilitiesSMNRW Shareholders’ equitySMNRW overview →